Home Blog Blog Uncategorized WHO Approves Emergency Use Listing for China’s Sinopharm CCP Virus Vaccine

WHO Approves Emergency Use Listing for China’s Sinopharm CCP Virus Vaccine

The World Health Organization (WHO) on Friday approved China’s state-owned Sinopharm CCP virus vaccine for emergency use for adults over 18. This comes despite concerns raised by a separate group of WHO experts who said they had “very low confidence” regarding the risk of serious side-effects in some patients. The Sinopharm jab’s inclusion on the WHO’s emergency use listing allows it to be included in COVAX, a global program that provides vaccines mainly for poor countries. “This expands the list of [COVID-19] vaccines that COVAX can buy, and gives countries confidence to expedite their own regulatory approval, and to import and administer a vaccine,” WHO Director-General Tedros Adhanom Ghebreyesus told a briefing. The WHO had already given emergency approval to COVID-19 vaccines developed by Pfizer-BioNTech, AstraZeneca, Johnson & Johnson, and more recently, Moderna. The decision to approve Sinopharm’s vaccine was taken by WHO’s technical advisory group, which began meeting on …

Add a comment